According to the report by Expert Market Research (EMR), the global diabetes drugs market growth, reached a value of USD 70.73 billion in 2022. Aided by the escalating prevalence of diabetes and the growing range of therapeutic options, the market is projected to further grow at a CAGR of 5.3% between 2024 and 2032 to reach a value of USD 112.58 billion by 2032. Diabetes drugs include various types of medicines, such as insulin, metformin, DPP-4 inhibitors, SGLT-2 inhibitors, and GLP-1 receptor agonists, which are commonly used to regulate blood…
Diabetes Drugs Market Size, Share, Growth 2024-2032
